MARKET

MTP

MTP

Midatech Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.470
-0.040
-1.59%
After Hours: 2.390 -0.08 -3.24% 19:36 02/25 EST
OPEN
2.570
PREV CLOSE
2.510
HIGH
2.630
LOW
2.310
VOLUME
459.93K
TURNOVER
--
52 WEEK HIGH
7.07
52 WEEK LOW
0.8620
MARKET CAP
31.31M
P/E (TTM)
-0.4694
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Global Oral Mucositis Drugs Market 2020 Segmentation, Statistics, Top Manufacturers, Regional Analysis and Forecast to 2025
Feb 21, 2021 (CDN Newswire via Comtex) -- The market research report entitled Global Oral Mucositis Drugs Market 2020 by Manufacturers, Regions, Type and...
CDN Newswire · 4d ago
Enhancing Drug Delivery Systems With Lexaria's Technology
Lexaria Bioscience was one of the Benzinga Global Small-Cap Conference sponsors on December 8-9, 2020. The information contained in this article in no way represents investment advice or opinion on the part of Benzinga or its writers and is intended for in...
Benzinga · 02/17 14:06
Midatech Pharma PLC Announces Exercise of Warrants and Issue of Equity
ABINGDON, OXFORDSHIRE / ACCESSWIRE / February 17, 2021 / Midatech Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, announces that it has issued to .
ACCESSWIRE · 02/17 07:00
Neuroendocrine Tumor Drug Market Set to Witness Growth 2021, Emerging industries, Challenges and Threats Faced by Key Vendors, Development Trends, Share, Size, Demand and 2027 Forecast Research Report
Feb 17, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." The global “Neuroendocrine Tumor Drug...
The Express Wire · 02/17 05:03
Drugs for Oral Mucositis Market Size Research Report 2021 by Growth Rate, Revenue Estimates, Market Dynamics, Industry Trends and Forecast to 2027 Says Absolute Reports
Feb 10, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." “Drugs for Oral Mucositis Market” research...
The Express Wire · 02/10 10:31
Neuroendocrine Tumor Drug Market Size 2021 by Revenue Estimates, Capacity, Price, Gross Margin and Forecast to 2027 Research Report by Absolute Reports
Feb 09, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." “Neuroendocrine Tumor Drug Market”...
The Express Wire · 02/09 12:12
PTON ,U among premarket losers
ATA Creativity Global (AACG) -41% pared down yesterday's gain as Reddit users pump.Document Security Systems (DSS) -32% after pricing equity offering.Midatech Pharma (MTP) -21%.Twist Bioscience (TWST) -17% after JPMorgan downgrade.FirstMark Horizon Acquisi...
Seekingalpha · 02/05 13:34
Artificial Saliva Market Size 2021 Explosive Factors, Competitive Panorama, Share, Progression Status, Emerging Trends, Recent Development, Business Challenges and Forecast to 2025
Feb 05, 2021 (The Expresswire) -- Global “Artificial Saliva Market” report is extensive significant analyses of the Artificial Saliva industry and provides...
The Express Wire · 02/05 05:52
More
Forecast
EPSBVPSCFPS
No Data
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of MTP. Analyze the recent business situations of Midatech Pharma through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-2.53%
Pharmaceuticals & Medical Research
-1.34%
Key Executives
Non-Executive Chairman
Rolf Stahel
Chief Executive Officer/Chief Financial Officer/Director
Stephen Stamp
Chief Scientific Officer
Daniel Palmer
Other
Justin Barry
Other
Tim Sparey
Non-Executive Director
Simon De Vries
Non-Executive Independent Director
Simon Turton
  • Dividends
  • Splits
  • Insider Activity
No Data
About MTP
Midatech Pharma PLC is a research and development biopharmaceutical company that is focused on commercializing and developing products in oncology and other therapeutic areas. The Company operates through Pipeline Research and Development segment. The Pipeline Research and Development segment seeks to develop products using the nanomedicine and sustained release technology platforms. The Company develops chemo therapeutics or new immune therapeutics, using its drug delivery technologies. Q-Sphera platform is the polymer microsphere technology is used for sustained release at the microscale to prolong and control the release of therapeutics over an extended period of time from weeks to months. Midasolve platform is its nanosaccharide technology is used to dissolve drugs at the nanoscale so that they can be administered in liquid form directly and locally into tumours. Midacore platform is the gold nanoparticle technology that is used for targeting sites of disease at the nanoscale.

Webull offers kinds of Midatech Pharma PLC-ADR stock information, including NASDAQ:MTP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MTP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MTP stock methods without spending real money on the virtual paper trading platform.